PolaskeyMTChangCHDaftaryK, et al. The global prevalence of seborrheic dermatitis: a systematic review and meta-analysis. JAMA Dermatol. 2024;160:846-855.
2.
AdalsteinssonJAKaushikSMuzumdarS, et al. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol. 2020;29:481-489.
3.
GuptaAKRichardsonMPaquetM. Systematic review of oral treatments for seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2014;28:16-26.
4.
PopeEKowalskiETauskF. Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis. JAAD Case Rep. 2022;24:59-60.
5.
TekluMChungHJ. Letter in response to the case report “Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis”. JAAD Case Rep. 2023;42:45-46.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
